Tatva Chintan shares make strong debut, list at 95% premium over issue price

Tatva Chintan Pharma made a stellar debut on the stock markets on Thursday. The stocks got listed with a massive premium of 95 per cent against the issue price of ₹1,083.The stock made its debut at ₹2,111.80, zooming 94.99 per cent from the issue price on the Bombay Stock Exchange (BSE). It then hit the day’s high of ₹2,486.30, rallying 129.57 per cent.At the NSE, the stock listed at ₹2,111.85, registering a massive gain of 95 per cent.Tatva Chintan’s ₹500 crore initial public offer (IPO) had received strong investor response when it opened for subscription for five days – from…